Back to Authors

Kumar, Subodh

0000-0003-2174-970X

A5102010491 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 2

P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 856-857

10.1097/01.hs9.0000846732.06415.be

Gene expression signatures of conventional prognostic factors in multiple myeloma

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6606-6606

10.1200/jco.2005.23.16_suppl.6606